A Study of Vonapanitase (PRT-201) Administered Immediately After Radiocephalic Arteriovenous Fistula(AVF) Creation in Patients With Chronic Kidney Disease (CKD) (PATENCY-2)

New York Presbyterian Hospital-Weill Cornell Medical Center, New York

VA Pittsburg Healthcare System, Pittsburgh

Lehigh Valley Health Network, Allentown

Wake Forest, Winston-Salem

University of North Carolina at Chapel Hill, Chapel Hill

SC Nephrology and Hypertension Center, Inc., Orangeburg

University of Alabama at Birmingham, Birmingham

Knoxville Kidney Center, Knoxville

Greenwood Leflore Hospital, Greenwood

University of Louisville, Louisville

Cleveland Clinic, Cleveland

Lutheran Hospital Network of Indiana, Fort Wayne

VA Ann Arbor Healthcare System, Ann Arbor

Henry Ford Hospital, Detroit

The University of Iowa Hospitals and Clinics, Iowa City

University of Wisconsin School of Medicine and PH, Madison

University of Chicago, Chicago

RenalCare Associates, S.C., Peoria

Saint Luke's Hospital, Kansas City

Tulane University, New Orleans

Baylor College of Medicine, Houston

The Methodist Hospital, Houston

Cardiothoracis and Vascular Surgeons, Austin

AKDHC Medical Research Services, LLC, Phoenix

Banner University Medical Center Tucson, Tucson

AKDHC Medical Research Services, LLc, Tucson

Keck University Hospital at USC, Los Angeles

VA Medical Center Long Beach, Long Beach

Kaiser Permanente, San Diego

California Institute of Renal Research, San Diego

VA Loma Linda Healthcare System, Loma Linda

Kaiser Permanente Northern California, San Francisco

Lake Washington Vascular Center, Bellevue

Maine Medical Center, Portland

Brigham and Women's Hospital, Boston

University of Massachusetts Medical Center, Worcester

University of Alberta, Edmonton

Vancouver General Hospital, Vancouver

London Health Science Center, London

University Health Network Toronto General Hospital, Toronto

McGill University Health Centre- Royal Victoria Hospital, Montreal